81 results
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only … , access, misappropriation or modification and (iii) the Company and its subsidiaries have implemented backup and disaster recovery technology consistent
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also
424B5
PRAX
Praxis Precision Medicines Inc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
by the users of its regulated subsidiaries. Access to the DTC system is also available to others, which we sometimes refer to as indirect participants
S-3
jpg0lqzwuuwfmm81a
5 Mar 24
Shelf registration
9:08am
S-3
EX-1.2
zu9bsxjx2kv6 ttb
5 Mar 24
Shelf registration
9:08am
S-8
EX-99.1
u1szjsc5
31 Jan 24
Registration of securities for employees
4:20pm
8-K
EX-1.1
j090k4bfc32ofmy5
12 Jan 24
Other Events
5:23pm
424B5
6xe8 n2fkyhjojo51m8
12 Jan 24
Prospectus supplement for primary offering
5:20pm
424B5
sgkb6kwfj7ib0hl3o
10 Jan 24
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
7jmp5c78h c48gqd6
7 Dec 23
Entry into a Material Definitive Agreement
5:23pm
424B5
no5mc0jfw3zwkvcds
7 Dec 23
Prospectus supplement for primary offering
5:19pm
8-K
8abevqis595
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-1.1
wpb3gd owwm
20 Jun 23
Other Events
7:02am
424B5
craxog2f 73c
20 Jun 23
Prospectus supplement for primary offering
6:02am